The global Idiopathic Inflammatory Myopathy Treatment Market advances in JAK inhibitors, FcRn blockers, interferon-targeted therapies, CAR-T cell approaches, and subtype-specific biologics are transforming management of dermatomyositis, polymyositis, and related conditions.
According to Business Market Insights, the Idiopathic Inflammatory Myopathy Treatment Market size was valued at US$ 965.14...
Hebrew